Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
Table of Contents As filed with the Securities and Exchange Commission on May 6, 2022...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NOTICE OF EFFECTIVENESSEffective Date:September 28,
Table of Contents Filed pursuant to Rule 424(b)(3) Registration Number 333-259463...
Table of Contents As filed with the Securities and Exchange Commission on September 10, 2021...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...
false 0001623613 0001623613 2020-11-16 2020-11-16 UNITED STATES SECURITIES AND EXCHANGE...
NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File...
0001623613FALSE2020Q312/31P3Y00016236132020-01-012020-09-30xbrli:shares00016236132020-10-31iso4217:USDxbrli:...
false000162361300016236132020-08-062020-08-06 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON...
Mylan Announces Third Quarter 2020 Financial Results and Looks Ahead to the Launch of Viatris Inc. PR...
Mylan Announces Appointment of Experienced Pharmaceutical Executive Bill Szablewski as Head of Capital Markets...
Mylan and Pfizer Receive Clearance from the U.S. Federal Trade Commission for Proposed Combination of Mylan...
Pfizer Announces Record Date for the Proposed Transaction Mylan N.V. (NASDAQ: MYL) and Pfizer Inc. (NYSE: PFE) today announced that the U.S...
Mylan and Development Partner, Synthon, Win Significant European Patent Office Ruling Related to Copaxone®...
Mylan and Pfizer Receive European Commission Approval for Proposed Combination of Mylan and Upjohn The...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관
광고 없는 경험을 위해 가입하세요
지금 사용해 보세요
광고 유지